48 related articles for article (PubMed ID: 38558625)
1. A case of generalized pustular psoriasis following discontinuation of apremilast.
Yamashita T; Shimizuhira C; Hiwa R; Fukuoka M
J Dermatol; 2024 Jun; ():. PubMed ID: 38831640
[No Abstract] [Full Text] [Related]
2. The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios.
Rajagopalan M; Dogra S; Saraswat A; Varma S; Banodkar P
Psoriasis (Auckl); 2021; 11():109-122. PubMed ID: 34430450
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.
Bianchi L; Del Duca E; Romanelli M; Saraceno R; Chimenti S; Chiricozzi A
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1121-8. PubMed ID: 27376729
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab-Induced Rupioid Psoriasis Treated by Apremilast Without Interrupting the Ongoing Antineoplastic Treatment.
Ambrogio F; Rubino L; Laface C; Cazzato G; Foti C
Cureus; 2024 Feb; 16(2):e55249. PubMed ID: 38558625
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report.
Siciliano MA; Dastoli S; d'Apolito M; Staropoli N; Tassone P; Tagliaferri P; Barbieri V
Front Oncol; 2020; 10():579445. PubMed ID: 33163407
[TBL] [Abstract][Full Text] [Related]
6. A Novel Approach to the Treatment of Pembrolizumab-induced Psoriasis Exacerbation: A Case Report.
Monsour EP; Pothen J; Balaraman R
Cureus; 2019 Oct; 11(10):e5824. PubMed ID: 31754559
[TBL] [Abstract][Full Text] [Related]
7. Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.
AbuHilal M; Walsh S; Shear N
J Cutan Med Surg; 2016 Jul; 20(4):313-6. PubMed ID: 26848145
[TBL] [Abstract][Full Text] [Related]
8. Acitretin : A Review of its Pharmacology and Therapeutic Use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
[TBL] [Abstract][Full Text] [Related]
9. Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database.
Sbidian E; Billionnet C; Weill A; Maura G; Mezzarobba M
Br J Dermatol; 2020 Mar; 182(3):690-697. PubMed ID: 31021438
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous development of generalized pustular psoriasis and pemphigoid with multiple autoantibodies in a complete responder of pembrolizumab for lung cancer.
Kochi Y; Miyachi H; Tagashira R; Koga H; Ishii N; Sugiura K; Ikeda JI; Matsue H; Inozume T
J Dermatol; 2023 Oct; 50(10):1343-1346. PubMed ID: 37183481
[TBL] [Abstract][Full Text] [Related]
11. Rupioid psoriasis presents with extensive hyperkeratotic plaques.
Cavazos A; Benjanuwattra J; Morataya C; Abdelnabi M
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36858427
[No Abstract] [Full Text] [Related]
12. Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report.
Kim S; Sun JH; Kim H; Kim HK; Yang Y; Lee JS; Choi IA; Han HS
World J Clin Cases; 2023 Jan; 11(1):218-224. PubMed ID: 36687173
[TBL] [Abstract][Full Text] [Related]
13. Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance.
Bhardwaj M; Chiu MN; Pilkhwal Sah S
Cutan Ocul Toxicol; 2022 Mar; 41(1):73-90. PubMed ID: 35107396
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis caused by pembrolizumab treatment in advanced melanoma: A positive prognostic side effect?
D'Erme AM; Fidanzi C; Janowska A; Allegrini G; Barbara C; Cupini S; Viacava P; Bagnoni G
Dermatol Ther; 2021 Sep; 34(5):e15050. PubMed ID: 34212457
[No Abstract] [Full Text] [Related]
15. Onset of rupioid psoriasis after vasodilatory regimen initiation in a patient with pulmonary arterial hypertension.
Rakita U; Trivedi M; Grushchak S; Wallis LS; Franco JC; Krunic AL
JAAD Case Rep; 2021 Jun; 12():77-80. PubMed ID: 34041338
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
